SEC11A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.186600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.932400E-01
Normal-vs-Stage2
9.007400E-01
Normal-vs-Stage3
6.800000E-01
Normal-vs-Stage4
6.077200E-01
Stage1-vs-Stage2
7.182800E-01
Stage1-vs-Stage3
5.581600E-01
Stage1-vs-Stage4
2.171600E-01
Stage2-vs-Stage3
3.755600E-01
Stage2-vs-Stage4
6.272000E-01
Stage3-vs-Stage4
2.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.913600E-01
Normal-vs-AfricanAmerican
9.821200E-01
Normal-vs-Asian
7.493200E-01
Caucasian-vs-AfricanAmerican
8.211000E-01
Caucasian-vs-Asian
3.024600E-01
AfricanAmerican-vs-Asian
6.526800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.311800E-01
Normal-vs-Female
9.012200E-01
Male-vs-Female
9.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.978600E-01
Normal-vs-Age(41-60Yrs)
5.087200E-01
Normal-vs-Age(61-80Yrs)
8.031200E-01
Normal-vs-Age(81-100Yrs)
9.151800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.374600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.211200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.686800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.003500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.733000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.173600E-01
Normal-vs-Daily Drinker
7.553200E-01
Normal-vs-Weekly Drinker
9.229200E-01
Normal-vs-Occasional Drinker
6.898600E-01
Normal-vs-Social Drinker
7.912600E-01
Non Drinker-vs-Daily Drinker
5.835800E-01
Non Drinker-vs-Weekly Drinker
9.546000E-01
Non Drinker-vs-Occasional Drinker
3.222800E-01
Non Drinker-vs-Social Drinker
7.586200E-01
Daily Drinker-vs-Weekly Drinker
7.346000E-01
Daily Drinker-vs-Occasional Drinker
1.803980E-01
Daily Drinker-vs-Social Drinker
8.349800E-01
Weekly Drinker-vs-Occasional Drinker
4.806000E-01
Weekly Drinker-vs-Social Drinker
8.652000E-01
Occasional Drinker-vs-Social Drinker
2.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.637200E-01
Normal-vs-Grade 2
9.326600E-01
Normal-vs-Grade 3
9.195000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.497500E-02
Grade 1-vs-Grade 3
1.777620E-01
Grade 1-vs-Grade 4
8.637200E-01
Grade 2-vs-Grade 3
6.919400E-01
Grade 2-vs-Grade 4
9.326600E-01
Grade 3-vs-Grade 4
9.195000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.757400E-01
Normal-vs-NonDiabetic
9.487600E-01
Diabetic-vs-NonDiabetic
4.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.700400E-01
Normal-vs-NoPancreatitis
9.801200E-01
Pancreatitis-vs-NoPancreatitis
2.706200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.759600E-01
Normal-vs-N1
8.307000E-01
N0-vs-N1
1.513210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.646400E-01
Normal-vs-TP53-NonMutant
6.111800E-01
TP53-Mutant-vs-TP53-NonMutant
7.661200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
